PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Zollinger-Ellison Syndrome D015043 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Decapitation D049248 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
HTLV-I Infections D015490 3 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Nasal Obstruction D015508 4 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Sneezing D012912 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Folliculitis D005499 7 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Pandey HP et al. Circadian variations of prostaglandins D2, E2, and F2 alpha in the cerebrospinal fluid of anesthetized rats. 1995 Biochem. Biophys. Res. Commun. pmid:7646520
Boie Y et al. Molecular cloning and characterization of the human prostanoid DP receptor. 1995 J. Biol. Chem. pmid:7642548
Araki M et al. Isoflurane modulates phorbol myristate acetate-, prostaglandin D2-, and prostaglandin E2-induced alterations in hepatic flow and metabolism in the perfused liver in fasted rats. 1994 Anesth. Analg. pmid:7639362
Hu ZQ et al. An essential role of prostaglandin E on mouse mast cell induction. 1995 J. Immunol. pmid:7636261
Ikai K et al. Effect of cytotoxic prostaglandin, delta 12-prostaglandin J2 on E-cadherin expression in transformed epidermal cells in culture. 1995 Prostaglandins Leukot. Essent. Fatty Acids pmid:7630918
Lee JH et al. Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells. 1995 FEBS Lett. pmid:7628635
Serrero G and Lepak NM Prostaglandin F2 alpha inhibits epidermal growth factor binding to cellular receptors on adipocyte precursors in primary culture. 1995 Biochem. Biophys. Res. Commun. pmid:7626101
Peden DB and Dailey L Modulation of mast cell functions by in vitro ozone exposure. 1995 Am. J. Physiol. pmid:7611432
Kawata R et al. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. 1995 J. Immunol. pmid:7608559
Matsumoto K et al. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. 1995 J. Biochem. pmid:7608139
Terao A et al. Roles of prostaglandins D2 and E2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. 1995 J. Neurochem. pmid:7595573
Murakami M et al. IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2. 1995 J. Immunol. pmid:7594606
Hespeling U et al. Feedback-inhibition of glucagon-stimulated glycogenolysis in hepatocyte/Kupffer cell cocultures by glucagon-elicited prostaglandin production in Kupffer cells. 1995 Hepatology pmid:7590678
De Vries GW et al. An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. 1995 Br. J. Pharmacol. pmid:7582550
Hartmann K et al. Effect of CC chemokines on mediator release from human skin mast cells and basophils. 1995 Int. Arch. Allergy Immunol. pmid:7580286
Rabe KF et al. Hydrogen peroxide contracts human airways in vitro: role of epithelium. 1995 Am. J. Physiol. pmid:7573466
Murakami M et al. Interleukin-3 regulates development of the 5-lipoxygenase/leukotriene C4 synthase pathway in mouse mast cells. 1995 J. Biol. Chem. pmid:7559381
Negishi M et al. Involvement of protein kinase in delta 12-prostaglandin J2-induced expression of rat heme oxygenase-1 gene. 1995 FEBS Lett. pmid:7556684
Reanmongkol W et al. Inhibitory effect of alkaloids extracted from the stem bark of Hunteria zeylanica on 5-lipoxygenase activity in vitro. 1995 Biol. Pharm. Bull. pmid:7550132
Ko FN et al. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. 1995 Biochim. Biophys. Acta pmid:7548232
Charlesworth EN Role of basophils and mast cells in acute and late reactions in the skin. 1995 Chem. Immunol. pmid:7546286
Horn EH et al. Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. 1995 Clin. Sci. pmid:7545563
Marone G et al. Human heart mast cells in anaphylaxis and cardiovascular disease. 1995 May-Jun Int. Arch. Allergy Immunol. pmid:7542106
Murakami M et al. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7541141
Murakami M et al. The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. 1995 J. Exp. Med. pmid:7540649
Parker J et al. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication. 1995 Antiviral Res. pmid:7537950
Leal-Berumen I et al. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. 1995 J. Immunol. pmid:7536779
Crankshaw DJ and Gaspar V Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes. 1995 J. Reprod. Fertil. pmid:7535849
Patella V et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. 1995 J. Immunol. pmid:7533185
Kaye AD et al. Analysis of thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1995 Crit. Care Med. pmid:7528116
Ko FN et al. YC-1, a novel activator of platelet guanylate cyclase. 1994 Blood pmid:7527671
Takei M and Endo K Histamine release and calcium concentrations in rat mast cells are dependent on intracellular ATP: effects of prostaglandin D2. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:7524104
Polosa R et al. [Mast cell mediator release after endobronchial challenge with adenosine 5'-monophosphate in asthmatic subjects]. 1994 Apr-Jun Ann. Ital. Med. Int. pmid:7522500
Darius H et al. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. 1994 Eur. J. Pharmacol. pmid:7522176
Okayama Y et al. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. 1994 Allergy pmid:7518654
D'Onofrio C et al. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction. 1994 Leukemia pmid:7516027
Warren JB et al. PGD2 is an intermediate in agonist-stimulated nitric oxide release in rabbit skin microcirculation. 1994 Am. J. Physiol. pmid:7515584
el-Lati SG et al. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. 1994 J. Invest. Dermatol. pmid:7513741
Jaffar ZH and Pearce FL Some characteristics of the ATP-induced histamine release from and permeabilization of rat mast cells. 1993 Agents Actions pmid:7511869
Closa D et al. Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats. 1994 Pancreas pmid:7509066
Ishimoto T et al. Contribution of phospholipases A2 and D to arachidonic acid liberation and prostaglandin D2 formation with increase in intracellular Ca2+ concentration in rat peritoneal mast cells. 1994 Eur. J. Biochem. pmid:7508386
Hay DW et al. Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. 1993 Br. J. Pharmacol. pmid:7507780
Casolaro V et al. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. 1993 J. Pharmacol. Exp. Ther. pmid:7505332
Spatz M et al. Prostaglandin D2 and endothelin-1 induce the production of prostaglandin F2 alpha, 9 alpha, 11 beta-prostaglandin F2, prostaglandin E2, and thromboxane in capillary endothelium of human brain. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:7505058
Fernandes B and Crankshaw D Functional characterization of the prostanoid DP receptor in human myometrium. 1995 Eur. J. Pharmacol. pmid:7498323
Hayaishi O and Matsumura H Prostaglandins and sleep. 1995 Adv. Neuroimmunol. pmid:7496614
Rangachari PK et al. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? 1995 J. Pharmacol. Exp. Ther. pmid:7473146
McRea JC et al. Prostaglandin releasing polymers - stability and efficacy. 1981 Trans Am Soc Artif Intern Organs pmid:7036503
Nakagawa S et al. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1). 1981 Proc Eur Dial Transplant Assoc pmid:7036145
Smith JB Prostaglandins and platelet aggregation. 1981 Acta Med. Scand. Suppl. pmid:7034481